Medical Economics November 27, 2024
Richard Payerchin

Key Takeaways

  • Patients are curious about GLP-1 RA antiobesity medications, necessitating discussions with healthcare providers.
  • Dr. Robert Kushner, an expert in obesity and nutrition, stresses the importance of initiating these conversations.
  • Informed dialogue between patients and providers is crucial for addressing concerns and understanding medication roles.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Patients have lots of questions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Physician, Provider, Trends
Related Articles:
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Happy Holidays: Is Your Doctor Happy? Are You Happy With Your Doctor?
Health for the Holidays: 3 Strategies for Empowering Medication Adherence
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
Memory Loss Is Not Always Dementia. A Neurologist Explains

Share This Article